FR314F - - Google Patents

Info

Publication number
FR314F
FR314F FR144905A FR144905A FR314F FR 314 F FR314 F FR 314F FR 144905 A FR144905 A FR 144905A FR 144905 A FR144905 A FR 144905A FR 314 F FR314 F FR 314F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR144905A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR144905A priority Critical patent/FR314F/fr
Priority to BE729914D priority patent/BE729914A/xx
Priority to GB1380069A priority patent/GB1196229A/en
Priority to DE19691914456 priority patent/DE1914456A1/en
Application granted granted Critical
Publication of FR314F publication Critical patent/FR314F/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
FR144905A 1968-03-22 1968-03-22 Expired FR314F (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR144905A FR314F (en) 1968-03-22 1968-03-22
BE729914D BE729914A (en) 1968-03-22 1969-03-14
GB1380069A GB1196229A (en) 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
DE19691914456 DE1914456A1 (en) 1968-03-22 1969-03-21 Papaverine glyoxylate vasodilator spasmolytic etc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (en) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
FR314F true FR314F (en) 1970-05-25

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
FR144905A Expired FR314F (en) 1968-03-22 1968-03-22

Country Status (4)

Country Link
BE (1) BE729914A (en)
DE (1) DE1914456A1 (en)
FR (1) FR314F (en)
GB (1) GB1196229A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2332921T3 (en) 2003-06-17 2016-08-31 Arena Pharm Inc 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
CA2529320C (en) 2003-06-17 2013-03-05 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
SI1833473T1 (en) 2004-12-23 2010-01-29 Arena Pharm Inc 5ht2c receptor modulator compositions and methods of use
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
ES2522587T3 (en) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Processes for preparing (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzacepin and intermediates thereof
EP2288585A1 (en) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2012030939A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
CN103189359A (en) 2010-09-01 2013-07-03 艾尼纳制药公司 Salts of lorcaserin with optically active acids
CN107669687A (en) 2010-09-01 2018-02-09 艾尼纳制药公司 5 HT for body weight control2CThe modified release dosage form of activator
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
US20150297610A1 (en) 2012-10-09 2015-10-22 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DE1914456A1 (en) 1971-06-16
BE729914A (en) 1969-09-15
GB1196229A (en) 1970-06-24

Similar Documents

Publication Publication Date Title
AU428130B2 (en)
AU5184069A (en)
FR314F (en)
AU6168869A (en)
AU429879B2 (en)
AU4304568A (en)
AU2581067A (en)
AU4811568A (en)
AU421558B1 (en)
AU3224368A (en)
AU4744468A (en)
AU2580267A (en)
AU3789668A (en)
BE709479A (en)
BE728646A (en)
BE709435A (en)
AU4464266A (en)
BE709415A (en)
AU2889368A (en)
AU4503667A (en)
BE728616A (en)
BE709320A (en)
BE709319A (en)
BE709301A (en)
BE709274A (en)